Adhera Therapeutics, Inc. (ATRX)

Adhera Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Sep 30, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Net Income	-4.49	-2.11	-6.35	-3.77	-11.98	-16.76
Depreciation & Amortization	-	-	-	-	0.08	0.33
Other Amortization	1.79	1.81	0.4	0.84	0.36	0.11
Loss (Gain) From Sale of Assets	-	-	-	-	0.06	-
Asset Writedown & Restructuring Costs	-	-	-	-	1.12	5.18
Stock-Based Compensation	-	-	-	0.01	0.77	1.45
Provision & Write-off of Bad Debts	-	-	-	-	0.03	0.07
Other Operating Activities	1.36	-1.31	5.28	0.94	0.35	1.49
Change in Accounts Receivable	-	-	-	-	0.02	-0.12
Change in Inventory	-	-	-	-	-0.24	-0.2
Change in Accounts Payable	0.1	0.07	0.09	0.85	1.13	-0.7
Change in Other Net Operating Assets	0.43	0.14	-0.09	0.54	-0.43	-0.45
Operating Cash Flow	-0.71	-1.42	-0.67	-0.59	-8.74	-9.61
Capital Expenditures	-	-	-	-	-	-0.07
Investing Cash Flow	-	-	-	-	-	-0.07
Short-Term Debt Issued	-	2.3	0.84	0.65	5.68	-
Total Debt Issued	0.89	2.3	0.84	0.65	5.68	-
Short-Term Debt Repaid	-	-0.58	-	-	-	-0.14
Total Debt Repaid	-0.21	-0.58	-	-	-	-0.14
Net Debt Issued (Repaid)	0.67	1.72	0.84	0.65	5.68	-0.14
Repurchase of Common Stock	-	-0	-	-	-	-0.25
Other Financing Activities	-0.06	-0.35	-0.1	-0.11	-0.71	-
Financing Cash Flow	0.61	1.37	0.74	0.54	4.87	13.5
Miscellaneous Cash Flow Adjustments	-	-	0	-	-	-
Net Cash Flow	-0.1	-0.04	0.08	-0.05	-3.87	3.81
Free Cash Flow	-0.71	-1.42	-0.67	-0.59	-8.74	-9.69
Free Cash Flow Margin	-	-	-	-	-3467.46%	-12743.42%
Free Cash Flow Per Share	-0.20	-0.61	-1.02	-1.08	-16.12	-17.87
Cash Interest Paid	-	0.09	-	-	-	-
Levered Free Cash Flow	0.56	-6.06	9.14	2.31	-2.43	-7.27
Unlevered Free Cash Flow	0.77	-5.9	9.64	2.58	-2.38	-7.29
Change in Working Capital	0.63	0.2	0.01	1.4	0.48	-1.48

Updated Nov 20, 2023. Source: S&P Global Market Intelligence. Standard template. Financial Sources.